Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Kegeles, L S; Abi-Dargham, A; Zea-Ponce, Y; Rodenhiser-Hill, J; Mann, J J; Van Heertum, R L; Cooper, T B; Carlsson, A; Laruelle, M

Kegeles, L S; Abi-Dargham, A; Zea-Ponce, Y; Rodenhiser-Hill, J; Mann, J J; Van Heertum, R L; Cooper, T B; Carlsson, A; Laruelle, M.

Affiliation

Kegeles LS; Department of Psychiatry, Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute, New York, New York 10032, USA.

Biol Psychiatry ; 48(7): 627-40, 2000 Oct 01.

Article in En | MEDLINE | ID: mdl-11032974

Subject(s)

Amphetamine/pharmacology; Corpus Striatum/drug effects; Dopamine Agents/pharmacology; Dopamine/metabolism; Excitatory Amino Acid Antagonists/pharmacology; Ketamine/pharmacology; Schizophrenia/physiopathology; Adult; Benzamides; Corpus Striatum/physiopathology; Dopamine Antagonists; Female; Humans; Male; Prefrontal Cortex/drug effects; Prefrontal Cortex/physiopathology; Pyrrolidines; Receptors, N-Methyl-D-Aspartate/drug effects; Receptors, N-Methyl-D-Aspartate/physiology; Synaptic Transmission/drug effects; Synaptic Transmission/physiology; Tomography, Emission-Computed, Single-Photon

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Dopamine Agents / Dopamine / Excitatory Amino Acid Antagonists / Corpus Striatum / Amphetamine / Ketamine Limits: Adult / Female / Humans / Male Language: En Journal: Biol Psychiatry Year: 2000 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links